PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios

Addex Therapeutics Ltd (ADXN)

Equity · Currency in USD · Last updated Oct 4, 2023
SummaryFinancials

Company Info

ISINUS00654J1079
CUSIP00654J107
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$8.21M
EPS-$1.31
Revenue (TTM)$2.15M
Gross Profit (TTM)$1.44M
EBITDA (TTM)-$12.74M
Year Range$0.34 - $2.28
Short %0.05%
Short Ratio2.54

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Addex Therapeutics Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%MayJuneJulyAugustSeptemberOctober
-50.77%
3.41%
ADXN (Addex Therapeutics Ltd)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ADXN

Addex Therapeutics Ltd

Return

Addex Therapeutics Ltd had a return of -40.80% year-to-date (YTD) and -52.78% in the last 12 months.


PeriodReturnBenchmark
1 month-17.84%-6.34%
6 months-59.60%3.14%
Year-To-Date-40.80%10.16%
1 year-52.78%14.98%
5 years (annualized)-67.31%-3.53%
10 years (annualized)N/AN/A

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-53.84%-24.99%-8.54%-19.74%7.49%-16.61%-17.77%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Addex Therapeutics Ltd (ADXN) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ADXN
Addex Therapeutics Ltd
-0.52
^GSPC
S&P 500
1.05

Sharpe Ratio

The current Addex Therapeutics Ltd Sharpe ratio is -0.52. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-0.500.000.501.00MayJuneJulyAugustSeptemberOctober
-0.52
1.05
ADXN (Addex Therapeutics Ltd)
Benchmark (^GSPC)

Dividend History


Addex Therapeutics Ltd doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%MayJuneJulyAugustSeptemberOctober
-98.46%
-11.82%
ADXN (Addex Therapeutics Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Addex Therapeutics Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Addex Therapeutics Ltd is 98.57%, recorded on Sep 27, 2023. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.57%Dec 28, 2020692Sep 27, 2023
-57.31%Jan 31, 202010Mar 23, 202044Aug 7, 202054
-53.38%Aug 10, 202058Nov 30, 202017Dec 24, 202075

Volatility Chart

The current Addex Therapeutics Ltd volatility is 33.76%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%MayJuneJulyAugustSeptemberOctober
33.76%
3.35%
ADXN (Addex Therapeutics Ltd)
Benchmark (^GSPC)